Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Revolut and Spotify investor Lakestar secures $265m continuation vehicle
Revolut and Spotify investor Lakestar secures $265m continuation vehicle Lakestar has raised a $265m continuation fund to extend its investments in selected portfolio companies, marking one of the largest such vehicles in European venture capital, according to...
GTCR explores private debt financing for potential $5.8bn Zentiva acquisition
GTCR explores private debt financing for potential $5.8bn Zentiva acquisition GTCR is in talks with direct lenders, including KKR, to raise financing for a potential acquisition of Prague-based drugmaker Zentiva, according to Bloomberg. The deal could value the...
Apollo explores bid for Costa Coffee as Coca-Cola weighs £2bn sale
Apollo explores bid for Costa Coffee as Coca-Cola weighs £2bn sale Apollo Global Management, the owner of Wagamama’s parent The Restaurant Group, has entered early-stage talks with advisers to Coca-Cola regarding a potential acquisition of Costa Coffee, according to...